HBV and HCV testing outcomes among marginalized communities in Italy, 2019–2024: a prospective studyResearch in context

HBV and HCV testing outcomes among marginalized communities in Italy, 2019–2024: a prospective studyResearch in context

Background: The health of the marginalized populations is crucial for public health and inequalities. The World Health Organization (WHO) Global Hepatitis Report 2024 stated that over 304 million people were living with Hepatitis B Virus (HBV)/Hepatitis C Virus (HCV) infection in 2022. We performed...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Lancet regional health. Europe 2025-02, Vol.49, p.101172
Hauptverfasser: Monica Monti, Teresita Caruso, Alice Castellaccio, Irene De Giorgi, Gabriella Cavallini, Maria Laura Manca, Serena Lorini, Silvia Marri, Luisa Petraccia, Francesco Madia, Cristina Stasi, Laura Carraresi, Elisabetta Lorefice, Sara Irene Bonelli, Alessandro Nerli, Mouheb M.A. Mudalal, Lorenzo Martini, Stefano Gitto, Eleonora Carradori, Adela Xheka, Irene Bendini, Samuele Lukolic’, Lorenzo Latella, Donatella Aquilini, Pierluigi Blanc, Anna Linda Zignego, Laura Gragnani
Format: Artikel
Sprache:eng
Schlagworte:
Healthcare disparities
Hepatitis B virus
Hepatitis C virus
Marginalized populations
World Health Organization
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Background: The health of the marginalized populations is crucial for public health and inequalities. The World Health Organization (WHO) Global Hepatitis Report 2024 stated that over 304 million people were living with Hepatitis B Virus (HBV)/Hepatitis C Virus (HCV) infection in 2022. We performed HBV/HCV screenings among marginalized communities to reveal hidden infections and link-to-care positive participants. Methods: From January 2019 to May 2024, finger-prick tests were used to conduct on-site screenings at non-profit organizations in Tuscany, Italy. Positive participants were referred to the closest outpatient clinic. Findings: Eighty/1812 (4.4%) participants were Hepatitis B surface Antigen (HBsAg)+, mostly men (p 
ISSN:2666-7762